(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 35.71%73.35M | 11.19%71.34M | 84.16%66.69M | 20.39%234.94M | 28.14%80.52M | -3.21%54.05M | 39.26%64.16M | 19.12%36.22M | 46.61%195.15M | 91.96%62.83M |
Net income from continuing operations | 71.83%32.95M | 2,777.89%19.14M | 186.37%14.14M | 169.81%19.41M | 253.55%15.94M | 142.63%19.18M | 109.84%665K | 11.84%-16.37M | -42.56%-27.8M | 14.39%-10.38M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.86%407K | --0 |
Depreciation and amortization | 17.20%35.81M | 19.95%33.13M | 10.29%31.89M | 15.29%117.87M | 8.64%30.78M | 19.23%30.55M | 13.46%27.62M | 20.81%28.91M | 15.68%102.23M | 20.82%28.33M |
Deferred tax | --0 | --0 | --0 | 51.72%-886K | 69.84%-628K | -847.77%-1.85M | --0 | --1.59M | 42.13%-1.84M | 67.26%-2.08M |
Other non cash items | -73.08%504K | 130.52%532K | -56.68%5.24M | -26.60%14.29M | -69.60%2.06M | -71.30%1.87M | -156.89%-1.74M | 290.07%12.1M | 1,373.35%19.46M | 1,379.48%6.78M |
Change In working capital | -1,380.26%-22.89M | -139.12%-7.46M | 37.33%-14.19M | -47.73%-22.44M | -83.52%1.54M | 117.62%1.79M | 48.14%-3.12M | -170.94%-22.65M | -93.32%-15.19M | 8,354.87%9.33M |
-Change in receivables | 7.49%-5.53M | -30.14%-7.38M | -14.24%-5.86M | 14.93%-22.67M | 7.59%-5.89M | 22.94%-5.98M | -1.69%-5.67M | 26.06%-5.13M | -28.82%-26.65M | -2.46%-6.38M |
-Change in prepaid assets | -562.46%-9.25M | 55.56%-1.6M | -6.85%-2.74M | -573.67%-9.59M | -157.60%-2.02M | -55.63%-1.4M | 47.63%-3.61M | -190.33%-2.57M | -226.02%-1.42M | 178.01%3.51M |
-Change in payables and accrued expense | 593.92%4.79M | 89.79%-395K | 70.45%-3.26M | -301.40%-11.08M | -50.98%4.79M | 77.78%-970K | -136.69%-3.87M | -5.51%-11.03M | -41.73%5.5M | 79.79%9.78M |
-Change in other working capital | -227.27%-12.9M | -80.87%1.92M | 40.49%-2.34M | 183.22%20.9M | 93.16%4.66M | 251.94%10.14M | 344.63%10.03M | -163.45%-3.92M | 226.89%7.38M | 506.75%2.41M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 35.71%73.35M | 11.19%71.34M | 84.16%66.69M | 20.39%234.94M | 28.14%80.52M | -3.21%54.05M | 39.26%64.16M | 19.12%36.22M | 46.61%195.15M | 91.96%62.83M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,411.30%-59.76M | -125.30%-34.35M | -56.98%46.45M | 134.94%401.15M | 185.52%152.89M | 110.88%4.56M | 449.80%135.75M | 109.63%107.96M | -910.66%-1.15B | 265.26%53.55M |
Capital expenditure reported | -179.31%-59.8M | -39.44%-34.35M | -80.13%-45.23M | -8.25%-124.81M | -84.85%-53.66M | 35.62%-21.41M | 11.06%-24.64M | 0.84%-25.11M | -11.44%-115.3M | 11.19%-29.03M |
Net PPE purchase and sale | --42K | --0 | --0 | -75.94%236K | --0 | --0 | -49.12%230K | -98.69%6K | 98.58%981K | -95.09%14K |
Net intangibles purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 12.79%-4.92M | --0 |
Net business purchase and sale | ---- | ---- | ---- | 67.55%-99.02M | 4,628.57%317K | ---- | ---- | ---- | -6,003.40%-305.17M | ---7K |
Net investment purchase and sale | --0 | --0 | -32.37%91.68M | 187.32%627.25M | 149.77%206.23M | -57.74%125.31M | 3,152.37%160.16M | 112.41%135.56M | ---718.35M | --82.57M |
Net other investing changes | ---- | ---- | ---- | 53.70%-2.5M | --0 | --0 | --0 | 37.50%-2.5M | ---5.4M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,411.30%-59.76M | -125.30%-34.35M | -56.98%46.45M | 134.94%401.15M | 185.52%152.89M | 110.88%4.56M | 449.80%135.75M | 109.63%107.96M | -910.66%-1.15B | 265.26%53.55M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 84.47%-16.83M | 87.15%-12.95M | 95.74%-11.25M | 23.18%-468.9M | 2,390.45%4.43M | -105.37%-108.35M | 74.81%-100.76M | -67.36%-264.23M | -138.31%-610.36M | -99.98%178K |
Net issuance payments of debt | -45.41%-1.38M | ---1.36M | ---1.36M | ---2.26M | ---1.31M | ---947K | --0 | --0 | --0 | --0 |
Net common stock issuance | 88.97%-11.7M | 90.86%-9.41M | 96.70%-8.77M | 18.59%-488.46M | ---13.51M | -112.06%-106.03M | 74.25%-103.02M | -77.27%-265.9M | -260.26%-600M | --0 |
Proceeds from stock option exercised by employees | 6.86%3.94M | -49.56%4.51M | 2.51%5.67M | 123.24%43.39M | 557.43%25.23M | 94.98%3.69M | 7.88%8.93M | 2.01%5.54M | -16.73%19.44M | -62.35%3.84M |
Net other financing activities | -52.05%-7.7M | -0.13%-6.68M | -75.78%-6.79M | 27.60%-21.58M | -63.42%-5.98M | -8.84%-5.06M | 18.50%-6.67M | 70.96%-3.86M | -834.99%-29.8M | -792.68%-3.66M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 84.47%-16.83M | 87.15%-12.95M | 95.74%-11.25M | 23.18%-468.9M | 2,390.45%4.43M | -105.37%-108.35M | 74.81%-100.76M | -67.36%-264.23M | -138.31%-610.36M | -99.98%178K |
Net cash flow | ||||||||||
Beginning cash position | 239.87%444.86M | 1,226.68%420.81M | 110.12%318.98M | -91.15%151.81M | 130.75%81.11M | 76.61%130.89M | -93.21%31.72M | -91.15%151.81M | 1,572.98%1.72B | -94.06%35.15M |
Current changes in cash | 93.51%-3.23M | -75.75%24.04M | 184.87%101.89M | 110.69%167.19M | 104.05%237.84M | -28.26%-49.74M | 125.25%99.16M | 90.38%-120.06M | -196.93%-1.56B | -89.62%116.56M |
Effect of exchange rate changes | 80.00%-8K | -64.29%5K | -127.59%-66K | 93.98%-15K | -59.60%40K | 77.40%-40K | 111.48%14K | 40.82%-29K | -5,080.00%-249K | --99K |
End cash Position | 444.48%441.62M | 239.87%444.86M | 1,226.68%420.81M | 110.12%318.98M | 110.12%318.98M | 130.75%81.11M | 76.61%130.89M | -93.21%31.72M | -91.15%151.81M | -91.15%151.81M |
Free cash flow | -58.47%13.56M | -6.42%36.99M | 93.26%21.47M | 46.97%110.13M | -20.56%26.86M | 44.47%32.64M | 193.70%39.53M | 118.64%11.11M | 212.10%74.94M | 71,823.40%33.8M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
No Data
No Data